Related references
Note: Only part of the references are listed.Dysregulation of the NLRP3 Inflammasome in Diabetic Retinopathy and Potential Therapeutic Targets
Karanvir S. Raman et al.
OCULAR IMMUNOLOGY AND INFLAMMATION (2022)
Diabetic nephropathy with and without retinopathy: comparison between urine and serum vascular endothelial growth factor
Hanisah Abdul Hamid et al.
INTERNATIONAL JOURNAL OF DIABETES IN DEVELOPING COUNTRIES (2022)
Etanercept as a TNF-alpha inhibitor depresses experimental retinal neovascularization
Yixuan Yao et al.
GRAEFES ARCHIVE FOR CLINICAL AND EXPERIMENTAL OPHTHALMOLOGY (2021)
Pro-inflammatory cytokine profile is present in the serum of Mexican patients with different stages of diabetic retinopathy secondary to type 2 diabetes
Jonathan Uriel Quevedo-Martinez et al.
BMJ OPEN OPHTHALMOLOGY (2021)
Connexin43 hemichannel block inhibits NLRP3 inflammasome activation in a human retinal explant model of diabetic retinopathy
Henry H. Louie et al.
EXPERIMENTAL EYE RESEARCH (2021)
The innate immune system in diabetic retinopathy
Warren W. Pan et al.
PROGRESS IN RETINAL AND EYE RESEARCH (2021)
Effect of Intravitreous Anti-Vascular Endothelial Growth Factor vs Sham Treatment for Prevention of Vision-Threatening Complications of Diabetic Retinopathy The Protocol W Randomized Clinical Trial
Raj K. Maturi et al.
JAMA OPHTHALMOLOGY (2021)
NLRP3 Inflammasome and Inflammatory Diseases
Zheng Wang et al.
OXIDATIVE MEDICINE AND CELLULAR LONGEVITY (2020)
Concentrations of Selected Cytokines and Vascular Endothelial Growth Factor in Aqueous Humor and Serum of Diabetic Patients
Katarina Cvitkovic et al.
SEMINARS IN OPHTHALMOLOGY (2020)
Interleukin-6 trans-signaling inhibition prevents oxidative stress in a mouse model of early diabetic retinopathy
Rebekah Robinson et al.
REDOX BIOLOGY (2020)
Inhibiting the NLRP3 inflammasome with MCC950 ameliorates retinal neovascularization and leakage by reversing the IL-1β/IL-18 activation pattern in an oxygen-induced ischemic retinopathy mouse model
Ailing Sui et al.
CELL DEATH & DISEASE (2020)
The Role of Inflammation in Diabetic Retinopathy
John V. Forrester et al.
FRONTIERS IN IMMUNOLOGY (2020)
The Evolving Treatment of Diabetic Retinopathy
Sam E. Mansour et al.
CLINICAL OPHTHALMOLOGY (2020)
Effect of Initial Management With Aflibercept vs Laser Photocoagulation vs Observation on Vision Loss Among Patients With Diabetic Macular Edema Involving the Center of the Macula and Good Visual Acuity A Randomized Clinical Trial
Carl W. Baker et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2019)
Anti-VEGF therapy: higher potency and long-lasting antagonism are not necessarily better
Ayumi Usui-Ouchi et al.
JOURNAL OF CLINICAL INVESTIGATION (2019)
The role of inflammation in diabetic eye disease
Marina Mesquida et al.
SEMINARS IN IMMUNOPATHOLOGY (2019)
Effects of etanercept on the apoptosis of ganglion cells and expression of Fas, TNF-α, caspase-8 in the retina of diabetic rats
Qin Ye et al.
INTERNATIONAL JOURNAL OF OPHTHALMOLOGY (2019)
IL-1 Family Cytokine Regulation of Vascular Permeability and Angiogenesis
Erin Fahey et al.
FRONTIERS IN IMMUNOLOGY (2019)
Global and regional diabetes prevalence estimates for 2019 and projections for 2030 and 2045: Results from the International Diabetes Federation Diabetes Atlas, 9th edition
Pouya Saeedi et al.
DIABETES RESEARCH AND CLINICAL PRACTICE (2019)
Inhibition of interleukin-6 trans-signaling prevents inflammation and endothelial barrier disruption in retinal endothelial cells
Maria L. Valle et al.
EXPERIMENTAL EYE RESEARCH (2019)
Interaction between microglia and retinal pigment epithelial cells determines the integrity of outer blood-retinal barrier in diabetic retinopathy
Dong Hyun Jo et al.
GLIA (2019)
Connexin43 hemichannel block protects against the development of diabetic retinopathy signs in a mouse model of the disease
Odunayo O. Mugisho et al.
JOURNAL OF MOLECULAR MEDICINE-JMM (2019)
Levels of Interleukin 27 and Interleukin 35 in the Serum and Vitreous of Patients with Proliferative Diabetic Retinopathy
Ai Yan et al.
OCULAR IMMUNOLOGY AND INFLAMMATION (2018)
Optimally estimating the sample mean from the sample size, median, mid-range, and/or mid-quartile range
Dehui Luo et al.
STATISTICAL METHODS IN MEDICAL RESEARCH (2018)
Levels of adhesion molecules in peripheral blood correlat with stages of diabetic retinopathy and may serve as bio markers for microvascular Checktor complications ARTICLE INFO ABSTRACT
Arnon Blum et al.
CYTOKINE (2018)
Early worsening of diabetic retinopathy after rapid improvement of blood glucose control in patients with diabetes
S. Feldman-Billard et al.
DIABETES & METABOLISM (2018)
The acute and chronic effects of intravitreal anti-vascular endothelial growth factor injections on intraocular pressure: A review
Peter Bracha et al.
SURVEY OF OPHTHALMOLOGY (2018)
Oxidative Stress and NLRP3-Inflammasome Activity as Significant Drivers of Diabetic Cardiovascular Complications: Therapeutic Implications
Arpeeta Sharma et al.
FRONTIERS IN PHYSIOLOGY (2018)
Diabetic retinopathy: a complex pathophysiology requiring novel therapeutic strategies
Michael Whitehead et al.
EXPERT OPINION ON BIOLOGICAL THERAPY (2018)
Pathophysiology of Diabetic Retinopathy: The Old and the New
Sentaro Kusuhara et al.
DIABETES & METABOLISM JOURNAL (2018)
Enhanced Expression of NLRP3 Inflammasome-Related Inflammation in Diabetic Retinopathy
Hui Chen et al.
INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE (2018)
The association of smoking and risk of diabetic retinopathy in patients with type 1 and type 2 diabetes: a meta-analysis
Xiaoling Cai et al.
ENDOCRINE (2018)
Activation of the TXNIP/NLRP3 inflammasome pathway contributes to inflammation in diabetic retinopathy: a novel inhibitory effect of minocycline
Wei Chen et al.
INFLAMMATION RESEARCH (2017)
Protection of Mcc950 against high-glucose-induced human retinal endothelial cell dysfunction
Yi Zhang et al.
CELL DEATH & DISEASE (2017)
Correlation of various serum biomarkers with the severity of diabetic retinopathy
M. Nalini et al.
DIABETES & METABOLIC SYNDROME-CLINICAL RESEARCH & REVIEWS (2017)
NLRP3 inflammasome activation is associated with proliferative diabetic retinopathy
Sirpa Loukovaara et al.
ACTA OPHTHALMOLOGICA (2017)
Persistent Effects of Intensive Glycemic Control on Retinopathy in Type 2 Diabetes in the Action to Control Cardiovascular Risk in Diabetes (ACCORD) Follow-On Study
Emily Y. Chew et al.
DIABETES CARE (2016)
Irisin modulates the association of interleukin-17A with the presence of non-proliferative diabetic retinopathy in patients with type 2 diabetes
Chuan Wang et al.
ENDOCRINE (2016)
Low blood and vitreal BDNF, LXA4 and altered Th1/Th2 cytokine balance are potential risk factors for diabetic retinopathy
Kuppan Kaviarasan et al.
METABOLISM-CLINICAL AND EXPERIMENTAL (2015)
NLRP3 inflammasome: From a danger signal sensor to a regulatory node of oxidative stress and inflammatory diseases
Amna Abderrazak et al.
REDOX BIOLOGY (2015)
IL-18 Immunotherapy for Neovascular AMD: Tolerability and Efficacy in Nonhuman Primates
Sarah L. Doyle et al.
INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE (2015)
Diabetic retinopathy: loss of neuroretinal adaptation to the diabetic metabolic environment
Steven F. Abcouwer et al.
YEAR IN DIABETES AND OBESITY (2014)
Estimating the sample mean and standard deviation from the sample size, median, range and/or interquartile range
Xiang Wan et al.
BMC MEDICAL RESEARCH METHODOLOGY (2014)
The interleukin-1 receptor antagonist anakinra improves endothelial dysfunction in streptozotocin-induced diabetic rats
Susana Vallejo et al.
CARDIOVASCULAR DIABETOLOGY (2014)
Ocular Anti-VEGF Therapy for Diabetic Retinopathy: The Role of VEGF in the Pathogenesis of Diabetic Retinopathy
Rafael Simo et al.
DIABETES CARE (2014)
The Association of Serum Vascular Endothelial Growth Factor and Ferritin in Diabetic Microvascular Disease
Li Guo et al.
DIABETES TECHNOLOGY & THERAPEUTICS (2014)
Markers of the Progression of Complications in Patients with Type 2 Diabetes: A One-year Longitudinal Study
M. C. Preciado-Puga et al.
EXPERIMENTAL AND CLINICAL ENDOCRINOLOGY & DIABETES (2014)
Increased intravitreous interleukin-18 correlated to vascular endothelial growth factor in patients with active proliferative diabetic retinopathy
Zongming Song et al.
GRAEFES ARCHIVE FOR CLINICAL AND EXPERIMENTAL OPHTHALMOLOGY (2014)
Interleukin-18 Has Antipermeablity and Antiangiogenic Activities in the Eye: Reciprocal Suppression With VEGF
Jikui Shen et al.
JOURNAL OF CELLULAR PHYSIOLOGY (2014)
IL-18 Attenuates Experimental Choroidal Neovascularization as a Potential Therapy for Wet Age-Related Macular Degeneration
Sarah L. Doyle et al.
SCIENCE TRANSLATIONAL MEDICINE (2014)
Euglycemic progression: Worsening of diabetic retinopathy in poorly controlled type 2 diabetes in minorities
A. Shurter et al.
DIABETES RESEARCH AND CLINICAL PRACTICE (2013)
Role of Intravitreal Inflammatory Cytokines and Angiogenic Factors in Proliferative Diabetic Retinopathy
Jinzi Zhou et al.
CURRENT EYE RESEARCH (2012)
Global Prevalence and Major Risk Factors of Diabetic Retinopathy
Joanne W. Y. Yau et al.
DIABETES CARE (2012)
Recent advances in understanding the biochemical and molecular mechanism of diabetic retinopathy
Mohammad Shamsul Ola et al.
JOURNAL OF DIABETES AND ITS COMPLICATIONS (2012)
Ranibizumab and Bevacizumab for Treatment of Neovascular Age-Related Macular Degeneration
Daniel F. Martin et al.
OPHTHALMOLOGY (2012)
Sensing damage by the NLRP3 inflammasome
Jaklien C. Leemans et al.
IMMUNOLOGICAL REVIEWS (2011)
Interleukin-18: A Mediator of Inflammation and Angiogenesis in Rheumatoid Arthritis
Michael V. Volin et al.
JOURNAL OF INTERFERON AND CYTOKINE RESEARCH (2011)
Interleukin 18 induces angiogenesis in vitro and in vivo via Src and Jnk kinases
M. Asif Amin et al.
ANNALS OF THE RHEUMATIC DISEASES (2010)
Circulating monocyte chemoattractant protein-1 links to diabetic retinopathy in type 2 diabetic patients without renal dysfunction
Shuhei Morita et al.
DIABETOLOGY INTERNATIONAL (2010)
Intravitreal Anakinra Inhibits Choroidal Neovascular Membrane Growth in a Rat Model
Jeffrey L. Olson et al.
OCULAR IMMUNOLOGY AND INFLAMMATION (2009)
Assessment of selected adhesion molecule and proinflammatory cytokine levels in the vitreous body of patients with type 2 diabetes - role of the inflammatory-immune process in the pathogenesis of proliferative diabetic retinopathy
Joanna Adamiec-Mroczek et al.
GRAEFES ARCHIVE FOR CLINICAL AND EXPERIMENTAL OPHTHALMOLOGY (2008)
Plasma concentration of pigment epithelium-derived factor in patients with diabetic retinopathy
Nahoko Ogata et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2007)
Inhibition of caspase-1/interleukin-1 beta signaling prevents degeneration of retinal capillaries in diabetes galactosemia
Jason A. Vincent et al.
DIABETES (2007)
Role of interleukin-1β in the pathogenesis of diabetic retinopathy
RA Kowluru et al.
BRITISH JOURNAL OF OPHTHALMOLOGY (2004)
Share Paper
